Long-term glucosamine use tied to dementia risk: systemic inflammation and metabolic pathways demand structural health policy reform
Original framing: “Glucosamine used for joint pain linked to dementia progression - Reuters” — Reuters (via Google News)
Post-colonial dietary shifts—replacement of whole foods with processed sugars and refined carbohydrates—correlate with rising dementia rates, paralleling the glucosamine supplement boom. The 20th-century medicalization of pain management diverted attention from dietary and lifestyle interventions. Historical precedents like the decline of Mediterranean diets in the 1970s show how structural economic changes drive health crises.
The glucosamine-dementia link reveals a systemic failure where biomedical reductionism obscures the metabolic roots of cognitive decline, while supplement industries profit from individualizing risk.
Historical dietary shifts—accelerated by colonialism and industrialization—have created environments where glucosamine, once a traditional remedy, becomes a metabolic disruptor. Indigenous health systems, with their holistic frameworks, offer proven alternatives, yet are sidelined by Western medical dominance. The solution lies in dismantling the supplement-industrial complex, reinvesting in food-as-medicine, and centering marginalized voices in health policy. Future-proofing requires recognizing that dementia is not a supplement problem but a symptom of a broken food system—one that trickster-like corporate actors exploit while solemnity conceals the absurdity of treating symptoms rather than causes.